Brain Health Supplements for Focus, Memory, and Clarity

Shilajit and peptides address different parts of the same problem. Shilajit restores the neuronal energy budget — giving your mitochondria the minerals, fulvic acids, and redox support they need to produce ATP efficiently. Peptides are precision signals that tell specific tissues what to repair or optimise. Without the energy foundation, the peptide signals have nothing to work with. Without the peptide signals, the energy has no directed purpose. Each amplifies the other — which is why the protocol is designed as a system, not a menu.

Cycling is intentional. Bioregulatory peptides work in phases: an active dosing period signals the target tissue, then a different product the following month allows consolidation and prevents receptor adaptation. If you took the same peptide every month indefinitely, your cells would adapt to the signal and the response would diminish. The 3-month rotation is built around this biology — active months drive adaptation, consolidation months let the changes settle. That's why continuing the protocol over time compounds results rather than plateauing.

Most subscribers report initial effects within 2–4 weeks — improved energy, clearer mornings, and better sleep quality tend to be the first things people notice. Marked improvements in cognitive endurance, focus duration, and recovery typically become consistent at 3–4 months. The shilajit often produces the fastest early results because it addresses the energy and transport deficits directly. The peptide effects build more gradually as gene expression patterns shift over repeated cycles.

Pürblack peptides are oral capsules — no injections required. The IPH peptide family consists of very short-chain sequences (2–5 amino acids) that are absorbed intact via the PepT1 transporter in the gut wall — the same pathway your body uses to absorb dietary dipeptides from food. This is biologically well-supported science, not a workaround. At their therapeutic doses (measured in micrograms), these peptides have shown no cytotoxic or oncological activity in cell culture studies. They are not WADA-banned. They are classified as food supplements, not pharmaceuticals. That said, if you have a specific health condition or are taking prescription medication, you should consult a healthcare professional before starting any new supplement protocol.

Most shilajit on the market is oxidised powder, industrial humic acid, or outright fake resin — none of which delivers the bioactive fulvic compounds and mineral profile that make shilajit clinically meaningful. Pürblack uses a patented Live Resin process backed by 5 US patents covering supercritical purification, gold and silver micro-particle integration, and resin-within-resin microdroplets — the only clinical-grade shilajit manufactured in the US. Every batch is independently third-party tested and carries a unique traceability ID. The difference is real and measurable at the molecular level.

Yes. You can swap any product in your monthly delivery for another product from the Pürblack range. If your protocol includes White Rabbit Vive and you'd prefer True Gold for a particular month, just make the change before your next billing date. Your subscription tier and discount remain the same.

Yes to both. You can pause your subscription for one or more months without losing your discount tier or your place in the cycle. You can cancel anytime before your next billing date with no penalty and no phone call required. We'd rather you pause than cancel — but we make both equally easy.

Physical recovery and cognitive performance share the same upstream biology. Systemic inflammation — the kind that accumulates from sedentary work, chronic stress, poor sleep, and inadequate recovery — directly impairs focus, working memory, and stress resilience. Muscle+ reduces pro-inflammatory cytokines (TNF-alpha ↓ 61%, IL-1beta ↓ 32% in animal studies) and supports cellular recovery. Joint+ reduces the low-grade inflammatory load from connective tissue stress. Both products lower the inflammatory noise that competes with cognitive performance — even if you never set foot in a gym.

The IPH peptide research programme includes cell culture studies, animal models, and human clinical trials. The most extensive is Muscle+ (IPH-AGAA): a 77-person human trial over 6 months showing +4.9kg muscle mass, -4.0kg fat, and +21.8% strength index. Vascular+ (IPH-AVN) has a 98-patient clinical study showing vascular stiffness reduction from 9.16 to 6.11 m/s. We want to be honest: these studies originate primarily from overlapping research groups, and independent third-party replication is still limited. The mechanistic rationale is sound and the clinical signals are consistent — but this is an emerging category, not a decades-old pharmaceutical evidence base. We publish the evidence and its limitations because we think you deserve to see both.

More is not always better with bioregulatory peptides. Dose-response studies on the IPH family show a biphasic curve: at higher concentrations, biological effects plateau or can reverse. The therapeutic window is precisely the dose used in the clinical trials — which is what the subscription delivers. The value of the Elite tier is the breadth of system coverage, not higher doses of the same products. The protocol is designed to deliver the right signal, at the right dose, in the right sequence.